2026-10-30 07:03:08 UTC#543414duplicateconfirmednews
AstraZeneca 9M revenue up 7% at CER, Core EPS rises 14%; FY guidance reaffirmed
quartrimportance 0.40trust 0.70AstraZeneca PLC +0.40Summit Therapeutics Inc. +0.30Farxiga -0.20+1 entities
SMMT stock news
SMMT stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire20 wire items
2026-10-29 00:01:28 UTC#533436newconfirmeddata release
UK vehicle production rose 36.3% year-over-year to 74,031 units in September, SMMT reports
financial_juiceimportance 0.40trust 0.80Society of Motor Manufacturers and Traders 0United Kingdom 0
2026-10-29 00:01:00 UTC#533460duplicateconfirmeddata release
UK vehicle production rose 36.3% in September to 74,031 units, SMMT reports
reutersimportance 0.30trust 0.90Society of Motor Manufacturers and Traders 0United Kingdom +0.20European Union +0.20+2 entities
2026-10-25 18:31:28 UTC#511614newconfirmednews
Summit Therapeutics reports survival benefit for cancer drug in clinical trial
2026-10-25 15:52:00 UTC#511410newconfirmednews
Summit Therapeutics' ivonescimab shows OS superiority vs durvalumab in Phase III biliary tract cancer trial
tradingviewimportance 0.60trust 0.70Summit Therapeutics Inc. +0.80Akeso, Inc. +0.80ivonescimab +0.80+2 entities
2026-10-24 01:26:00 UTC#509536duplicateconfirmedpress release
Lunit and Summit Therapeutics partner to apply SCOPE IO AI platform for tumor microenvironment analysis
2026-10-24 01:26:00 UTC#509535newconfirmedpress release
Lunit and Summit Therapeutics partner to use Lunit SCOPE IO AI platform for ivonescimab tumor microenvironment analysis
pr_newswireimportance 0.40trust 0.90Lunit Inc. +0.30Summit Therapeutics Inc. +0.30Lunit SCOPE IO +0.30+1 entities
2026-10-21 12:45:28 UTC#493088duplicateconfirmednews
Akeso and Summit Therapeutics partner with ECOG-ACRIN for Phase II/III Ivonescimab trial in biliary tract cancer
2026-10-21 12:42:00 UTC#493036newconfirmedpress release
Akeso and Summit Therapeutics partner with ECOG-ACRIN for Phase II/III trial of Ivonescimab in biliary tract cancer
pr newswireimportance 0.50trust 0.90Akeso, Inc. +0.40Summit Therapeutics Inc. +0.40ECOG-ACRIN Cancer Research Group +0.30+1 entities
2026-10-19 11:33:15 UTC#480009newconfirmednews
Summit Therapeutics initiates Phase II study of ivonescimab-based regimens in advanced clear cell renal cell carcinoma
reutersimportance 0.40trust 0.80Summit Therapeutics Inc. +0.30Ivonescimab +0.30Renal Cell Carcinoma +0.20
2026-10-05 19:44:30 UTC#415612newconfirmednews
AstraZeneca CEO Soriot sees Summit drug as key to future cancer combination therapies
2026-10-05 11:00:00 UTC#412922duplicateconfirmednews
Summit Therapeutics closes $2B equity investment from AstraZeneca at $18.36 per share
tradingviewimportance 0.30trust 0.70Summit Therapeutics Inc. +0.60AstraZeneca PLC +0.30ivonescimab +0.50+1 entities
2026-10-05 11:00:00 UTC#412855newconfirmednews
Summit Therapeutics closes $2 billion strategic equity investment from AstraZeneca
2026-10-02 16:12:22 UTC#406325duplicateconfirmednews
Summit Therapeutics, AstraZeneca, and Daiichi Sankyo confirm clinical trial collaboration for cancer drug combo
reutersimportance 0.30trust 0.90Summit Therapeutics, Inc. +0.50AstraZeneca PLC +0.40Daiichi Sankyo Company, Limited +0.40+2 entities
2026-10-02 12:00:30 UTC#404911duplicateconfirmednews
AstraZeneca, Daiichi Sankyo, and Summit Therapeutics to Collaborate on Cancer Drug Combination Trials
bloombergimportance 0.30trust 0.80AstraZeneca PLC +0.30Daiichi Sankyo Company, Limited +0.30Summit Therapeutics Inc. +0.40
2026-10-02 10:19:00 UTC#404491duplicateconfirmednews
UK September New Car Sales Rose 12% to 350,518 Units, SMMT Says
2026-10-02 08:41:58 UTC#403988duplicateconfirmeddata release
UK September new car registrations rose 12.1% to 350,518 units, SMMT data confirms
reutersimportance 0.30trust 0.90Society of Motor Manufacturers and Traders 0Tesla, Inc. +0.30Jaecoo +0.30+1 entities
2026-10-02 08:07:15 UTC#403852duplicateconfirmeddata release
UK September New Car Registrations Rose 12.1% YoY, SMMT Data Confirms
2026-10-02 08:06:13 UTC#403840newconfirmeddata release
UK new car registrations rose 12.1% to 350,518 units in September, SMMT data shows
financial_juiceimportance 0.40trust 0.70Society of Motor Manufacturers and Traders 0United Kingdom 0
2026-10-02 06:58:00 UTC#403658duplicateconfirmednews
AstraZeneca, Daiichi Sankyo, and Summit Therapeutics to Partner on Cancer Drug Combination Trial
reutersimportance 0.30trust 0.90AstraZeneca PLC +0.30Daiichi Sankyo Company, Limited +0.30Summit Therapeutics Inc. +0.30